Nutrition and inflammation in fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at how nutrition and inflammation relate to a liver condition called MASLD (fatty liver disease). It aims to find patterns that may help guide better care for people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 to 65 years old
- Willing to sign a consent form to join the study
- No current acute infection (like a sudden severe illness)
- No major surgery or serious injury in the last 6 months
- No history of cancer
- No previous weight-loss surgery
- No liver cirrhosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what drives non-alcoholic fatty liver disease and how it affects the body, including immune-related changes. You may be invited if you have confirmed fatty liver disease or, alternatively, if you are a healthy person with no liver disease.
This study tests a more detailed way to examine the liver in people with fatty liver disease who also have other health risks. The doctors want to see if this extra testing helps decide whether you need treatment.
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
This study is looking for new ways to detect liver scarring (fibrosis) in people with fatty liver disease (NAFLD, NASH, MASLD, or MASH). If you qualify, you will give a blood sample to help identify biomarkers that could replace biopsies.
This study looks at whether people with a fatty liver have higher levels of inflammation markers in their blood. It aims to see if inflammation blood tests could help doctors better understand fatty liver disease.
This study looks at how common obesity is in people with fatty liver disease (a condition where fat builds up in the liver). It aims to understand the relationship between these two conditions better, which might lead to improved care and prevention.
Hear when a new Liver Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.